Immunogen (IMGN) call put ratio 22 calls to 1 put into AbbVie (ABBV) to acquire

Immunogen (NASDAQ: IMGN) December call option implied volatility is at 106, January is at 112; compared to its 52-week range of 50 to 217 into AbbVie (ABBV) to acquire ImmunoGen for $31.26 per share in cash. Call put ratio 22 calls to 1 put with focus on December 17 and January 21 calls into the bell.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• EchoStar Corp. (SATS) call put ratio 3.4 calls to 1 put as share price down 6.4%
• Woodside Energy (WDS) call put ratio 100 calls to 1 put with a focus on July 22.50 calls as share price up 5.8%